NCT05595460 - Study of RYZ101 in Combination With SoC in Subjects With SSTR+ ES-SCLC | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 10, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

March 31, 2029

Conditions

SCLC,Extensive Stage

Interventions

DRUG

RYZ101 Dose Level 1

Dose Level 1

DRUG

RYZ101 Dose Level 2

Dose Level 2

DRUG

RYZ101 Dose Level 3

Dose Level 3

DRUG

RYZ101 Dose Level -1

Dose Level -1

DRUG

Atezolizumab

DRUG

Carboplatin

DRUG

Etoposide

Trial Locations (15)

32224

RECRUITING

Research Facility, Jacksonville

32806

RECRUITING

Research Facility, Orlando

33136

RECRUITING

Research Facility, Miami

40536

RECRUITING

Reserach Facility, Lexington

48098

WITHDRAWN

Research Facility, Troy

49503

RECRUITING

Research Facility, Grand Rapids

52242

RECRUITING

Research Facility, Iowa City

55905

RECRUITING

Research Facility, Rochester

63130

RECRUITING

Research Facility, St Louis

68130

RECRUITING

Research Facility, Omaha

77090

WITHDRAWN

Research Facility, Houston

84112

RECRUITING

Research Facility, Salt Lake City

90024

RECRUITING

Research Facility, Los Angeles

94158

RECRUITING

Research Facility, San Francisco

00935

RECRUITING

Research Facility, San Juan

All Listed Sponsors

lead

RayzeBio, Inc.

INDUSTRY